BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17680854)

  • 1. Inflammatory cytokine imbalance after coronary angioplasty: links with coronary atherosclerosis.
    Brunetti ND; Munno I; Pellegrino PL; Ruggiero V; Correale M; Cuculo A; De Gennaro L; Campanale G; Mavilio G; Ziccardi L; Di Biase M
    J Interv Cardiol; 2007 Aug; 20(4):248-57. PubMed ID: 17680854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis -- comparison with stable and unstable angina.
    Kozinski M; Krzewina-Kowalska A; Kubica J; Zbikowska-Gotz M; Dymek G; Piasecki R; Sukiennik A; Grzesk G; Bogdan M; Chojnicki M; Dziedziczko A; Sypniewska G
    Inflamm Res; 2005 May; 54(5):187-93. PubMed ID: 15953990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th2-dependent cytokine release in patients treated with coronary angioplasty.
    Brunetti ND; Pepe M; Munno I; Tiecco F; Quagliara D; De Gennaro L; Gaglione A; Di Biase M; Favale S
    Coron Artery Dis; 2008 May; 19(3):133-7. PubMed ID: 18418228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the systemic levels of inflammatory markers after percutaneous coronary intervention with bare metal versus sirolimus-eluting stents.
    Rebeiz AG; Zoghbi E; Harb R; Youhanna S; Skouri HN; Dimassi A; Abou-Nader G; Nasrallah A; Sawaya J; Gharzuddine W; Alam S
    J Interv Cardiol; 2009 Apr; 22(2):169-74. PubMed ID: 19245380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical implication and association between local and systemic levels of interleukin-1β and interleukin-10 in patients with coronary artery disease].
    Yan HB; Li WZ; Zhao HJ; Song L; Zheng B; Zhou P; Liu C
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Feb; 39(2):142-6. PubMed ID: 21426749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of tachykinin and cytokine release in patients with coronary disease undergoing percutaneous revascularization.
    Paroli M; Mariani P; Accapezzato D; D'Alessandro M; Di Russo C; Bifolco M; Sirinian MI; Fedele F; Bruno G; Sardella G
    Clin Immunol; 2004 Jul; 112(1):78-84. PubMed ID: 15207784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of percutaneous coronary intervention on the levels of interleukin-6 and C-reactive protein in the coronary circulation of subjects with coronary artery disease.
    Ramadan MM; Kodama M; Mitsuma W; Ito M; Kashimura T; Ikrar T; Hirono S; Okura Y; Aizawa Y
    Am J Cardiol; 2006 Oct; 98(7):915-7. PubMed ID: 16996873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early elevation of interleukin-1beta and interleukin-6 levels after bare or drug-eluting stent implantation in patients with stable angina.
    Sardella G; Mariani P; D'Alessandro M; De Luca L; Pierro M; Mancone M; Porretta A; Accapezzato D; Fedele F; Paroli M
    Thromb Res; 2006; 117(6):659-64. PubMed ID: 16005497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-18/interleukin-10 ratio is an independent predictor of recurrent coronary events during a 1-year follow-up in patients with acute coronary syndrome.
    Chalikias GK; Tziakas DN; Kaski JC; Kekes A; Hatzinikolaou EI; Stakos DA; Tentes IK; Kortsaris AX; Hatseras DI
    Int J Cardiol; 2007 May; 117(3):333-9. PubMed ID: 16859776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial changes in plasma levels of cytokines in patients with coronary artery disease.
    Heinisch RH; Zanetti CR; Comin F; Fernandes JL; Ramires JA; Serrano CV
    Vasc Health Risk Manag; 2005; 1(3):245-50. PubMed ID: 17319110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-inflammatory/anti-inflammatory cytokine imbalance in acute coronary syndromes.
    Pasqui AL; Di Renzo M; Bova G; Maffei S; Pompella G; Auteri A; Puccetti L
    Clin Exp Med; 2006 Mar; 6(1):38-44. PubMed ID: 16550343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of outcomes of percutaneous coronary intervention on proximal versus non-proximal left anterior descending coronary artery, proximal left circumflex, and proximal right coronary artery: a cross-sectional study.
    Alidoosti M; Salarifar M; Zeinali AM; Kassaian SE; Dehkordi MR
    BMC Cardiovasc Disord; 2007 Mar; 7():7. PubMed ID: 17335586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparison of early inflammatory response after sirolimus-eluting stent vs bare metal stent implantation in native coronary lesions.
    Li JJ; Qin XW; Yang XC; Li ZC; Zeng HS; Xu B; Gao Z; Wu YJ; Zhang X; Zhang CY
    Clin Chim Acta; 2008 Oct; 396(1-2):38-42. PubMed ID: 18634770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine response after percutaneous coronary intervention in stable angina: effect of selective glycoprotein IIb/IIIa receptor antagonism.
    Bonz AW; Lengenfelder B; Jacobs M; Strotmann J; Held S; Ertl G; Voelker W
    Am Heart J; 2003 Apr; 145(4):693-9. PubMed ID: 12679767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of long-term mortality after percutaneous coronary intervention in patients treated for acute ST-elevation myocardial infarction versus those with unstable and stable angina pectoris.
    Hirsch A; Verouden NJ; Koch KT; Baan J; Henriques JP; Piek JJ; Rohling WJ; van der Schaaf RJ; Tijssen JG; Vis MM; de Winter RJ
    Am J Cardiol; 2009 Aug; 104(3):333-7. PubMed ID: 19616663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.
    Daemen J; Kuck KH; Macaya C; LeGrand V; Vrolix M; Carrie D; Sheiban I; Suttorp MJ; Vranckx P; Rademaker T; Goedhart D; Schuijer M; Wittebols K; Macours N; Stoll HP; Serruys PW;
    J Am Coll Cardiol; 2008 Dec; 52(24):1957-67. PubMed ID: 19055986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models.
    Di Stefano R; Di Bello V; Barsotti MC; Grigoratos C; Armani C; Dell'Omodarme M; Carpi A; Balbarini A
    Biomed Pharmacother; 2009 Dec; 63(10):773-80. PubMed ID: 19906505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivessel percutaneous coronary intervention: a new paradigm for a new century.
    Morrison DA
    Minerva Cardioangiol; 2005 Oct; 53(5):361-77. PubMed ID: 16179881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.